Literature DB >> 27818763

Intravascular large B-cell lymphoma diagnosed at renal biopsy.

Manivarma Kamalanathan1, David Wright2, Rosalynd Johnston3, Andrew Webb4, Edward Kingdon1.   

Abstract

Entities:  

Year:  2012        PMID: 27818763      PMCID: PMC5094391          DOI: 10.1093/ckj/sfs159

Source DB:  PubMed          Journal:  Clin Kidney J        ISSN: 2048-8505


× No keyword cloud information.
A 77-year-old woman was referred with renal impairment—serum creatinine 230 mmol/L (2.61 mg/dL) and proteinuria 2.14 g/day. The past medical history included hypertension, sicca symptoms and osteoarthritis. Her medications included amlodipine 5 mg od, omeprazole 20 mg od and prednisolone 10 mg od. Systematic enquiry revealed lethargy and 6 kg weight loss over 6 months. Examination was unremarkable. Laboratory investigations revealed normocytic normochromic anaemia with reactive thrombocytosis. Serum lactate dehydrogenase was elevated. Bone biochemistry, liver function tests, serum protein electrophoresis, immunoglobulins, anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies and complements were all negative or normal. Ultrasound showed normal-sized unobstructed kidneys of normal echogenicity. A renal biopsy revealed an almost exclusively intraglomerular infiltrate of enlarged atypical CD20 positive B-lymphocytes filling the capillary lumens of nearly 50% of all glomeruli seen on the biopsy indicating large B-cell lymphoma of non-germinal centre immunophenotype (Figure 1a and 1b). No complement, immunoglobulin or amyloid deposits were present. Electron microscopy of a single glomerulus did not reveal any abnormal lymphocyte, but did reveal a segmental sclerosing lesion together with widespread basement membrane thickening and wrinkling. There were no electron dense deposits.
Fig. 1.

(a) Light microscopy showing infiltrated and non-infiltrated adjacent glomeruli. (b) Anti-CD20 antibodies reveal large atypical B-cells restricted to glomerular capillaries.

(a) Light microscopy showing infiltrated and non-infiltrated adjacent glomeruli. (b) Anti-CD20 antibodies reveal large atypical B-cells restricted to glomerular capillaries. Staging computed tomography (CT) including brain was normal and positron emission tomography scanning showed diffuse marrow activity but no abnormal renal signal. The clinical diagnosis was intravascular large B-cell lymphoma. Six cycles of standard rituximab plus multiagent chemotherapy were administered successfully. The patient was alive 4 years after completion of chemotherapy with independent renal function and modest proteinuria (serum creatinine 1.56 mg/dL, proteinuria 38 mg/day). The response CT showed continued normality. Intravascular large B-cell lymphoma is uncommon and is usually associated with a poor prognosis [1]. Isolated glomerular infiltration is extremely rare [2] and the characteristic pathologic finding is localization of lymphoma cells within the lumina of glomerular capillaries [3]. We describe a good outcome after the conventional treatment of intravascular large B-cell lymphoma identified during the investigation of proteinuric kidney disease.
  3 in total

Review 1.  Use of rituximab in diffuse large B-cell lymphoma in the salvage setting.

Authors:  Christian Gisselbrecht
Journal:  Br J Haematol       Date:  2008-10-16       Impact factor: 6.998

2.  Kidney-limited intravascular large B cell lymphoma: a distinct variant of IVLBCL?

Authors:  Yoshihiro Kameoka; Naoto Takahashi; Atsushi Komatsuda; Hiroyuki Tagawa; Keiko Hamai; Makoto Hirokawa; Hideki Wakui; Ryo Ichinohasama; Ken-Ichi Sawada
Journal:  Int J Hematol       Date:  2009-03-26       Impact factor: 2.490

3.  Intravascular large B-cell lymphoma of the kidney: a case report.

Authors:  Xiaoyan Bai; Xiao Li; Liyan Wan; Guobao Wang; Nan Jia; Jian Geng
Journal:  Diagn Pathol       Date:  2011-09-23       Impact factor: 2.644

  3 in total
  1 in total

1.  Renal Intravascular Large B-cell Lymphoma: A Case Report and Review of the Literature.

Authors:  Arnaud Desclaux; Estibaliz Lazaro; Jean-Baptiste Pinaquy; Mokrane Yacoub; Jean-Francois Viallard
Journal:  Intern Med       Date:  2017-04-01       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.